P. Cox

发表

Cyclophosphamide cystitis--identification of acrolein as the causative agent.

P. Cox, 1979, Biochemical pharmacology.

Ion channels as therapeutic targets: a drug discovery perspective.

R. M. Owen, A. Brown, E. Stevens, 2013, Journal of medicinal chemistry.

Identification of the alpha2-delta-1 subunit of voltage-dependent calcium channels as a molecular target for pain mediating the analgesic actions of pregabalin.

A. Dolphin, P. Cox, J. Offord, 2006, Proceedings of the National Academy of Sciences of the United States of America.

Interactions between the Mas-Related Receptors MrgD and MrgE Alter Signalling and Trafficking of MrgD

G. Milligan, J. Pediani, S. Milasta, 2006, Molecular Pharmacology.

Selection of potential second generation platinum compounds

Michael G. K. Jones, P. Cox, K. Harrap, 1978 .

Some studies of the active intermediates formed in the microsomal metabolism of cyclophosphamide and isophosphamide.

T. A. Connors, P. Farmer, P. Cox, 1974, Biochemical pharmacology.

Metabolism of N-nitrosomorpholine by the rat in vivo and by rat liver microsomes and its oxidation by the Fenton system.

P. Cox, M. Jarman, D. Manson, 1978, Chemico-biological interactions.

Presynaptic Calcium Channels as Drug Targets for Pain

E. Stevens, P. Cox, 2013 .

Tissue distribution and functional expression of the human voltage-gated sodium channel β3 subunit

E. Stevens, P. Cox, P. Richardson, 2000, Pflügers Archiv.

Design and pharmacological evaluation of PF-4840154, a non-electrophilic reference agonist of the TrpA1 channel.

T. Ryckmans, P. Cox, Linda Kitching, 2011, Bioorganic & medicinal chemistry letters.

Synthesis and first in vitro cytotoxicity studies of bis(2-chloroethyl) amino group containing polymers. Pharmacologically active polymers: 22

H. Ringsdorf, P. Cox, G. Abel, 1980 .

The discovery of a potent Nav1.3 inhibitor with good oral pharmacokinetics.

J. Warmus, P. Cox, C. Markworth, 2017, MedChemComm.

Copper(I) halide complexes of 5-carbethoxy-2-thiouracil: synthesis, structure and in vitro cytotoxicity.

T. Choli-Papadopoulou, C. Kokotidou, P. Cox, 2014, European journal of medicinal chemistry.

Stereoselectivity in the metabolism of the enantiomers of cyclophosphamide in mice, rats, and rabbits.

W. Stec, P. Farmer, P. Cox, 1978, Drug metabolism and disposition: the biological fate of chemicals.

Observations on the differential metabolism and biological activity of the optical isomers of cyclophosphamide.

P. Farmer, P. Cox, M. Jarman, 1976, Biochemical pharmacology.

Leptospiral motility

P. Cox, G. Twigg, 1974, Nature.

Isolation and identification of a metabolic intermediate in the selective dechloroethylation of one of the four stereoisomers of 4-methylcyclophosphamide.

W. Stec, P. Farmer, P. Cox, 1978, Cancer research.

Isolation and Identification of a Metabolic Intermediate in the Selective Dechloroethylation of One of the Four Stereoisomers of 4-Methylcyclophosphamide1

W. Stec, P. Farmer, P. Cox, 2006 .

Identification of the (cid:1) 2 - (cid:2) -1 subunit of voltage-dependent calcium channels as a molecular target for pain mediating the analgesic actions of pregabalin

A. Dolphin, P. Cox, J. Offord, 2006 .

Cyclophosphamide cystitis. Studies aimed at its minimization.

P. Cox, G. Abel, 1979, Biochemical pharmacology.

The binding of trichlorofluoromethane and other haloalkanes to cytochrome P-450 under aerobic and anaerobic conditions.

D. Parke, P. Cox, L. King, 1976, Xenobiotica; the fate of foreign compounds in biological systems.

Observations on kidney damage in hamsters following a non-icterohaemorrhagic form of disease resulting from infection by Leptospira interrogans serotype icterohaemorrhagiae.

P. Cox, G. Twigg, 1981, Journal of comparative pathology.

Tumor inhibitory triazenes. 3. Dealkylation within an homologous series and its relation to antitumor activity.

D. Newell, P. Cox, P. Goddard, 1984, Journal of medicinal chemistry.

Towards selectivity? Approaches to the design of new anti-tumour agents--II.

P. Farmer, P. Cox, 1977, Cancer treatment reviews.

The use of deuterated analogs in qualitative and quantitative investigations of the metabolism of cyclophosphamide (NSC-26271).

P. Farmer, P. Cox, M. Jarman, 1976, Cancer treatment reports.

Absorption, disposition, and metabolism of rosiglitazone, a potent thiazolidinedione insulin sensitizer, in humans.

P. Cox, A. M. Harris, H. Cowley, 2000, Drug metabolism and disposition: the biological fate of chemicals.

Subtype-Selective Small Molecule Inhibitors Reveal a Fundamental Role for Nav1.7 in Nociceptor Electrogenesis, Axonal Conduction and Presynaptic Release

Sulayman D. Dib-Hajj, Stephen G. Waxman, R. Ian Storer, 2016, PloS one.

New targets for neuropathic pain therapeutics

P. Cox, R. Kinloch, 2005, Expert opinion on therapeutic targets.

The enzymatic basis of the selective action of cyclophosphamide.

P. Cox, B. Phillips, P. Thomas, 1975, Cancer research.

Evidence for the active intermediate in cyclophosphamide metabolism.

P. Cox, 1973, British Journal of Cancer.

Novel metabolic products of cyclophosphamide in human urine.

P. Cox, L. Levin, 1975, Biochemical pharmacology.

Cyclophosphamide cystitis and bladder cancer. A hypothesis.

P. Cox, 1979, European journal of cancer.

beta 3: an additional auxiliary subunit of the voltage-sensitive sodium channel that modulates channel gating with distinct kinetics.

K Mizuguchi, K. Mizuguchi, E. Stevens, 2000, Proceedings of the National Academy of Sciences of the United States of America.

THE DISTRIBUTION OF LEPTOSPIRES IN THE KIDNEY TUBULES OF SOME BRITISH WILD MAMMALS

P. Cox, G. Twigg, 1976, Journal of wildlife diseases.

Studies on the selective action of cyclophosphamide (NSC-26271): Inactivation of the hydroxylated metabolite by tissue-soluble enzymes.

P. Cox, B. Phillips, P. Thomas, 1976, Cancer treatment reports.

CACHD1 is an α2δ-Like Protein That Modulates CaV3 Voltage-Gated Calcium Channel Activity

E. Stevens, M. Rigby, G. Cottrell, 2018, The Journal of Neuroscience.

The microsomal metabolism of some analogues of cyclophosphamide: 4-methylcyclophosphamide and 6-methylcyclophosphamide.

P. Farmer, P. Cox, M. Jarman, 1975, Biochemical pharmacology.

Infectious bovine keratoconjunctivitis: isolation of Moraxella bovis from two groups of young beef cattle in fly control field trials during 1981

P. Cox, J. Liddell, A. Mattinson, 1984, The Veterinary Record.

Use of Tween 80 agar in the study of Moraxella bovis infection in cattle

P. Cox, A. Mattinson, 1982, The Veterinary Record.

The effect of deletion of the orphan G – protein coupled receptor (GPCR) gene MrgE on pain-like behaviours in mice

S. Trim, P. Cox, R. Kinloch, 2008, Molecular pain.

A study of the possible metabolism of trichlorofluoromethane.

D. Parke, P. Cox, L. King, 1972, The Biochemical journal.

The Chimeric Approach Reveals That Differences in the TRPV1 Pore Domain Determine Species-specific Sensitivity to Block of Heat Activation*

C. Grimm, Lishuang Cao, E. Stevens, 2011, The Journal of Biological Chemistry.

In Vitro Methods for Use in Drug Metabolism Studies

P. Cox, B. Phillips, 1976 .

Application of deuterium labelling mass spectrometry in a study of the metabolism of the enantiomers of cyclophosphamide.

W. Stec, P. Farmer, P. Cox, 1977, Biomedical mass spectrometry.

Observations on the mechanism of hydroxylation of cyclophosphamide by rat liver microsomes: the metabolism of cyclophosphamide-4-d2.

T. A. Connors, P. Farmer, P. Cox, 1974, Biomedical mass spectrometry.

Metabolism of temelastine (SK&F 93944) in hepatocytes from rat, dog, cynomolgus monkey and man.

P. Cox, R. Chenery, H. Oldham, 1990, Drug metabolism and disposition: the biological fate of chemicals.

Determination of Residues in the Norepinephrine Transporter That Are Critical for Tricyclic Antidepressant Affinity*

Bruno Giros, B. Giros, M. Hamon, 2001, The Journal of Biological Chemistry.

Growth studies of various strains of T. vaginalis and possible improvements in the laboratory diagnosis of trichomoniasis.

C. Nicol, P. Cox, 1973, The British journal of venereal diseases.

The biological fate of some chlorofluoroalkanes

P. Cox, 1972 .

Discovery of a Series of Indazole TRPA1 Antagonists.

J. Warmus, P. Cox, K. Omoto, 2017, ACS medicinal chemistry letters.

The discovery of a potent series of carboxamide TRPA1 antagonists

J. Warmus, T. Ryckmans, P. Cox, 2016 .

The interaction of temelastine with cytochrome P450 mixed-function oxidase enzymes in vivo and in vitro.

P. Cox, R. Chenery, H. Oldham, 1989, Biochemical pharmacology.

Correlating Physiology with Gene Expression in Striatal Cholinergic Neurones

P. Cox, R. Pinnock, A. Dixon, 2000, Journal of neurochemistry.

Synthesis and antitumor activity of 6-trifluoromethylcyclophosphamide and related compounds.

P. Farmer, P. Cox, 1975, Journal of Medicinal Chemistry.

Synthesis and antitumor activity of 6-trifluoromethylcyclophosphamide and related compounds

P. Farmer, P. Cox, 1976 .

Tissue distribution and functional expression of the human voltage-gated sodium channel beta3 subunit.

E. Stevens, P. Cox, P. Richardson, 2001, Pflugers Archiv : European journal of physiology.